RICHMOND, Va., July 3, 2012 /PRNewswire/ -- Health Diagnostic Laboratory (HDL, Inc.) today announced that Tara Dall, MD has joined the growing advanced laboratory as Chief Medical Officer. Dr. Dall graduated in the first class of Diplomates of the American Board of Clinical Lipidology and her clinic has been nationally recognized as the first fully certified Level II lipid clinic in the United States.
"Health Diagnostic Laboratory represents a milestone in the medical community. The lives we are saving thanks to advanced testing mark a monumental shift in the way physicians can now detect life-threatening conditions. By adding Dr. Tara Dall, one of the most dedicated leaders in the fight against cardiovascular and related diseases, our lab will save even more lives and healthcare dollars in the years ahead," said Tonya Mallory, co-founder and CEO of HDL, Inc.
Dr. Dall attended University of Wisconsin-Madison for undergraduate, medical school training, and family medicine residency. Entering private practice in 2001, Dr. Dall formed the Cholesterol & Lifestyle Center in 2006 with the goal of aggressive detection and treatment of atherosclerotic cardiovascular disease. In 2008 she formed Advanced Lipidology, Early Detection Center for Heart Disease and Diabetes. She has a special interest in advanced lipid testing and CIMT technology, women's heart disease, polycystic ovarian syndrome and pediatric obesity. Dr. Dall also has extensive experience in diagnosis and treatment of insulin resistance and pre diabetes, and she lectures regularly on this topic. She served as the President Elect of the Midwest Lipid Association in 2011 and on the organization's board from 2006 to 2012. Dr. Dall is a published author in the field of lipidology and is known for her leadership in advanced biomarker testing.
"Dr. Dall has a deep level of knowledge, lifelong commitment, and leadership that is critical to Health Diagnostic Laboratory's goal of ridding the world of preventable cardiovascular and related diseases," said Mallory.
Dr. Dall will join a growing organization that is changing the way clinical laboratories interact with physicians and patients. The award-winning laboratory offers a comprehensive panel of tests to help physicians personalize treatment based on more complete patient profiling. As a result of the evidence-based approach at HDL, Inc., the medical community now has the ability to earlier detect risk factors pre-disposing patients to disease and to provide more personalized, cost effective treatments.
Health Diagnostic Laboratory, Inc. is about prevention rather than cure. Dr. Dall will help providers understand how the traditional use of low-density lipoprotein cholesterol, total cholesterol, high-density lipoprotein cholesterol and triglyceride values alone, fail to provide the critical information that physicians need in order to fully understand causative factors and effectively treat the disease. HDL, Inc.'s approach is to incorporate all aspects of the disease process. As a result, the advanced testing offered by HDL, Inc. can help identify exactly where a patient sits on the continuum of disease, the cause of the patient's specific disease state, and the best treatment options available.
About Health Diagnostic Laboratory, Inc.
Health Diagnostic Laboratory, Inc. (HDL, Inc.), a CAP accredited leader in health management, offers a comprehensive test menu of risk factors and biomarkers for cardiovascular and related diseases. Our systematic approach identifies factors contributing to disease and provides a basis for effective treatment, allowing physicians to more effectively manage patients. As an added value, patients receive a personalized overview of their risk factors along with intensive counseling from expert Health Coaches at no additional cost, improving compliance and enhancing satisfaction. For more information about HDL, please visit www.hdlabinc.com.
SOURCE HDL, Inc.